Source: Dow Jones News
By Angela Chen
Biogen Inc. will pay Applied Genetic Technologies Corp. $124 million for license and commercialization rights to several of its gene-based therapies for eye diseases.
The $124 million includes a $30 million equity investment at a price of $20.63 a share. Biogen also has the option to license discovery programs for three additional indications.
AGTC is eligible to receive milestone payments totaling more than $1 billion. This includes up to $472.5 million for the two lead programs and most of the rest coming from payments for the potential discovery programs.
The two lead programs covered in the agreement are a clinical candidate for a disease called X-linked Retinoschisis and a pre-clinical treatment for X-Linked Retinitis Pigmentosa. These are diseases of the retina that can cause blindness in men.
AGTC Chief Executive Sue Washer said the collaboration would "support the development of new therapies that may allow for transformative treatments for these rare inherited eye diseases."
Massachusetts-based Biogen has been in search of new products to drive sales growth following the successful 2013 launch of its multiple-sclerosis therapy Tecfidera. In its latest quarter, slowing growth of Tecfidera led to lower-than-expected profit and revenue growth.
Shares of Biogen have increased about 19% this year through Wednesday's close.
The deal is expected to close in the third quarter.
Write to Angela Chen at angela.chen@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM